Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Typhoid conjugate vaccine (Vi-CRM197) - Novartis Vaccines Institute for Global Health

Drug Profile

Typhoid conjugate vaccine (Vi-CRM197) - Novartis Vaccines Institute for Global Health

Alternative Names: NVGH glycoconjugate vaccine against S. typhi - Novartis; NVGH Vi-CRM197 vaccine; Salmonella monovalent typhi vaccine - NVGH; Typhoid conjugate vaccine - Novartis; Vi-CRM197; Vi-CRM197 glycoconjugated vaccine; Vi-CRM197 vaccine

Latest Information Update: 27 Jun 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Novartis Vaccines Institute for Global Health
  • Class Bacterial vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Typhoid

Most Recent Events

  • 19 Mar 2018 Typhoid conjugate vaccine is still in clinical trials for Typhoid (In volunteers, Prevention) in India (CTRI2018-03-012558)
  • 19 Mar 2018 Biological E Limited initiates a phase I trial for Typhoid (In volunteers, Prevention) in India (IM) (CTRI2018-03-012558)
  • 19 Aug 2015 No recent reports on development identified - Phase-II for Typhoid (In children, In infants, Prevention) in Philippines (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top